Health Care & Life Sciences » Pharmaceuticals | Daihan Pharmaceutical Co. Ltd.

Daihan Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Daihan Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Government Pension Fund - Global (The)
175,380
2.92%
-8,939
0%
12/31/2017
DFA Emerging Markets Core Equity Portfolio
46,727
0.78%
1,356
0.01%
04/30/2018
DFA Emerging Markets Small Cap Series
37,153
0.62%
0
0.02%
01/31/2018
Lemanik SICAV - Asian Opportunity
27,000
0.45%
-3,000
0.87%
08/31/2018
RAM (Lux) Systematic Funds - Emerging Markets Equities
21,592
0.36%
7,671
0.03%
06/30/2017
Fidelity Northstar Fund
20,000
0.33%
0
0.02%
07/31/2018
10,000
0.17%
0
0.02%
07/31/2018
6,462
0.11%
-45
0.02%
07/31/2018
TIFF Multi Asset Fund
5,918
0.1%
0
0.01%
06/30/2018
AXA Rosenberg Eq. Alpha Trust - Pacific (ex-Jap.) Small Cap
5,635
0.09%
0
0.1%
03/31/2018

About Daihan Pharmaceutical Co.

View Profile
Address
3 Seonyu-ro 45-gil
Seoul SL 07209
Korea, Republic Of
Employees -
Website http://www.daihan.com
Updated 09/14/2018
Daihan Pharmaceutical Co., Ltd. manufactures medical products. It operates through the following businesses: Manufacturing, Sales & Marketing, Research & Development, Quality Control and Overseas Business. Its Manufacturing business provides manufactures medicinal products.